参考文献/References:
［1］KOOT Y， TEKLENBURG G, SALKER M S, et al. Molecular aspects of implantation failure ［J］. Biochimica et Biophysica ActaMolecular Basis of Disease, 2012, 1822(12, S I): 1943-1950.
［2］POLANSKI L T, BAUMGARTEN M N, QUENBY S, et al. What exactly do we mean by 'recurrent implantation failure'? A systematic review and opinion ［J］. Reproductive BioMedicine Online, 2014, 28(4): 409-423.
［3］KAMMERER U, VON W M, MARKERT U R. Immunology of human endometrium［J］. Immunobiology, 2004, 209(7): 569-574.
［4］SVENSSON-ARVELUND J, ERNERUDH J. The role of macrophages in promoting and maintaining homeostasis at the FetalMaternal interface［J］. American Journal of Reproductive Immunology (New York, N.Y.： 1989), 2015, 74(2): 100-109.
［5］GNAINSKY Y, GRANOT I, ALDO P, et al. Biopsy-induced inflammatory conditions improve endometrial receptivity: the mechanism of action ［J］. Reproduction, 2015, 149(1): 75-85.
［6］HEIKKINEN J, MTTNEN M, KOMI J, et al. Phenotypic characterization of human decidual macrophages［J］. Clinical and Experimental Immunology, 2003, 131(3): 498-505.
［7］LIANG P-y, YIN B, CAI J, et al. Increased circulating Th1/Th2 ratios but not other lymphocyte subsets during controlled ovarian stimulation are linked to subsequent implantation failure after transfer of in vitro fertilized embryos［J］. American Journal of Reproductive Immunology, 2015, 73(1): 12-21.
［8］LIANG Pei-yan, DIAO Liang-hui, HUANG Chun-yu, et al. The pro-inflammatory and anti-inflammatory cytokine profile in peripheral blood of women with recurrent implantation failure ［J］. Reproductive BioMedicine Online, 2015, 31(6): 823-826.
［9］WANG Wen-juan, ZHANG Hong, CHEN Zhong-quan, et al. Endometrial TGF-β, IL-10, IL-17 and autophagy are dysregulated in women with recurrent implantation failure with chronic endometritis ［J］. Reproductive Biology and Endocrinology： RB&E, 2019, 17(1): 2.
［10］QI Hai, CHEN Xin, CHU C, et al. Tfh cell differentiation and their function in promoting B-cell responses［J］. Advances in Experimental Medicine and Biology, 2014, 841: 153-180.
［11］SHARMA S. Natural killer cells and regulatory T cells in early pregnancy loss［J］. The International Journal of Developmental Biology, 2014, 58(2-4): 219-229.
［12］PALACZ M, TREMELLEN K. High body mass index is associated with an expansion of endometrial T regulatory cell and macrophage populations ［J］. Journal of Reproductive Immunology, 2018, 129: 36-39.
［13］JIANG Ruiwei, YAN G, XING Jun, et al. Abnormal ratio of CD 57+ cells to CD 56+ cells in women with recurrent implantation failure［J］. American Journal of Reproductive Immunology (New York, N.Y.： 1989), 2017, 78(5): e 12708.
［14］ZHANG Jianhong, CHEN Zhilin, SMITH G N, et al. Natural killer cell-triggered vascular transformation: maternal care before birth?［J］. Cellular & Molecular Immunology, 2011, 8(1): 1-11.
［15］KUNICKI M, UKASZUK K, WOCLAWEK-POTOCKA I, et al. Evaluation of granulocyte colony-stimulating factor effects on treatment-resistant thin endometrium in women undergoing in vitro fertilization［J］. BioMed Research International, 2014(3): 913235.
［16］WANG Ji-meng, ZHAO Hong-xi, WANG Li, et al. The human leukocyte antigen G promotes trophoblast fusion and β-hCG production through the Erk1/2 pathway in human choriocarcinoma cell lines［J］. Biochemical and Biophysical Research Communications, 2013, 434(3): 460-465.
［17］NIU Ziru, WANG Liangyi, PANG R T, et al. A meta-analysis of the impact of human leukocyte antigen-G on the outcomes of IVF/ICSI ［J］. Reproductive BioMedicine Online, 2017, 34(6): 611-618.
［18］PERSSON G, MELSTED W N, NILSSON L L, et al. HLA class Ib in pregnancy and pregnancy-related disorders［J］. Immunogenetics, 2017, 69(8-9): 581-595.
［19］LASHLEY L E, VAN DER WESTERLAKEN L A, HAASNOOT G W, et al. Maternal HLA-C2 and 14 bp insertion in HLA-G is associated with recurrent implantation failure after in vitro fertilization treatment ［J］. Tissue Antigens, 2014, 84(6): 536-544.
［20］COUGHLAN C, SINAGRA M, LEDGER W, et al. Endometrial integrin expression in women with recurrent implantation failure after in vitro fertilization and its relationship to pregnancy outcome［J］. Fertility and Sterility, 2013, 100(3): 825-830.
［21］DEKEL N, GNAINSKY Y, GRANOT I, et al. The role of inflammation for a successful implantation［J］. American Journal of Reproductive Immunology, 2014, 72(2): 141-147.
［22］ZENG Hong, FAN Xiuli, LIU Nenghui. Expression of H19 imprinted gene in patients with repeated implantation failure during the window of implantation［J］. Archives of Gynecology and Obstetrics, 2017, 296(4): 835-839.
［23］CHIGHIZOLA C B, DE JESUS G R. Antiphospholipid antibodies and infertility ［J］. Lupus, 2014, 23(12): 1232-1238.
［24］SAUER R, ROUSSEV R, JEYENDRAN R S, et al. Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure［J］. Fertility and Sterility, 2010, 93(7): 2441-2443.
［25］YING Ying, ZHONG Yi-ping, ZHOU Can-quan, et al. Antinuclear antibodies predicts a poor IVF-ET outcome: impaired egg and embryo development and reduced pregnancy rate［J］. Immunological Investigations, 2012, 41(5): 458-468.
［26］NA Y c-b, ASIF S, RAINE-FENNING N J. Is there evidence to support serum antinuclear antibodies testing in women with recurrent implantation failure undergoing in vitro fertilization?［J］. Hum Fertil (Camb), 2017, 20(4): 224-226.
［27］TING A T, BERTRAND M J. More to Life than NF-κB in TNFR1 Signaling ［J］. Trends in Immunology, 2016, 37(8): 535-545.
［28］ERSAHIN A, ACET M, ACET T, et al. Disturbed endometrial NF-κB expression in women with recurrent implantation failure［J］. European Review for Medical and Pharmacological Sciences, 2016, 20(24): 5037-5040.
［29］FABIAN D, JUHS S, IL'KOV G, et al. Dose- and time-dependent effects of TNFalpha and actinomycin D on cell death incidence and embryo growth in mouse blastocysts［J］. Zygote (Cambridge, England), 2007, 15(3): 241-249.
［30］LDE N, PETITBARAT M, CHEVRIER L, et al. The uterine immune profile May help women with repeated unexplained embryo implantation failure after in vitro fertilization ［J］. American Journal of Reproductive Immunology, 2016, 75(3): 388-401.
［31］LDE N, GRIDELET V, RAVET S, et al. Impact of follicular GCSF quantification on subsequent embryo transfer decisions: a proof of concept study［J］. Human Reproduction (Oxford, England), 2013, 28(2): 406-413.
［32］WRFEL W. Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and/or recurrent spontaneous abortions［J］. Journal of Reproductive Immunology, 2015, 108: 123-135.
［33］THOUAS G A, DOMINGUEZ F, GREEN M P, et al. Soluble ligands and their receptors in human embryo development and implantation ［J］. Endocrine Reviews, 2015, 36(1): 92-130.
相似文献/References:
[1]吴小明,李强.体外受精与胚胎移植前输卵管积水处理方式的探讨[J].中国计划生育和妇产科,2009,(06):0.
[2]方伟芬,孙燕萍,牛向丽,等.体外受精后不同时期观察受精对胚胎质量的影响[J].中国计划生育和妇产科,2010,(01):0.
FANG Wei-fen,SUN Yan-ping,NIU Xiang-li,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(1):0.
[3]黄卡立,公方强,檀大羡,等.应用微刺激联合拮抗剂方案对76例卵巢低反应者进行体外受精-胚胎移植的临床研究[J].中国计划生育和妇产科,2010,(01):0.
HUANG Ka-li,GONG Fang-qiang,TAN Da-xianResearch centre of population and family planning of Guangxi Zhuang Autonomous Region,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(1):0.
[4]陈颖,扎西,李瑞文,等.垂体降调节后促性腺激素启动日两种雌二醇水平与体外受精-胚胎移植结局的关系[J].中国计划生育和妇产科,2010,(02):0.
CHEN Ying,ZHA Xi,LI Rui-wen,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(1):0.
[5]黄卡立,檀大羡.3种黄体支持方法在体外受精-胚胎移植术后对妊娠结局的影响[J].中国计划生育和妇产科,2010,(03):0.
HUANG Ka-Li,TAN Da-xian.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(1):0.
[6]李艳梅,李梦洁,柳雪琴,等.体外受精-胚胎移植患者的心理问题及其护理研究[J].中国计划生育和妇产科,2010,(03):0.
[7]孙燕萍,牛向丽,陈自洪,等.玻璃化与程序化两种不同胚胎冻融方法的临床应用效果比较[J].中国计划生育和妇产科,2011,(01):0.
SUN Yan-ping,NIU Xiang-li,CHEN Zi-hong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(1):0.
[8]梁雪飞,檀大羡,王书佳,等.长方案注射HCG日血清雌二醇/孕酮比值对体外受精-胚胎移植结局的影响[J].中国计划生育和妇产科,2011,(03):0.
LIANG Xue-fei,TAN Da-xian,WANG Shu-jia.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(1):0.
[9]周晓燕,刘雨生,骆丽华,等.超排卵长方案中长效与短效促性腺激素激动剂降调节效果比较[J].中国计划生育和妇产科,2011,(03):0.
[10]刘晓妍,张守信,沈肖方,等.缩短挽救性ICSI卵龄有助于改善完全受精失败周期的结局[J].中国计划生育和妇产科,2012,(02):0.
LIU Xiao-yan,ZHANG Shou-xin,SHEN Xiao-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(1):0.